Sunday, August 02, 2015 11:48:04 AM
I always look forward to your posts and typically you are spot on. My biggest problem is the "go it alone". The strategy just doesnt work for a small penny stock and company that requires massive capital to progress a pipeline.
Mgt. should be able to attract a high quality venture capital firm that truly believes in the Science. Everyone can still reach the same goals and make alot of money.
But most importantly, when a CEO blatantly has lied the way this one has..its time to go and be replaced (or per my advice...just take the company private and then the shareholders wont need to know and care how the business is orchestrated since it wont be publicly traded).
Note: MS Precise was to be commercially viable later this year...when did that all change? Can someone please help me understand why the expectation was built that way? So in reality, the CEO doesnt have a clue. LymPro was to garner a huge % of the RUO market? How does the CEO think that is true but an Analyst at Zacks had already figured out that it cant garner more than $1mm in potential sales. Somebody is not telling the truth...who seems to repeat the mistakes over and over?
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM